SEB Asset Management’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
Other funds holding NAMS
SEB Asset Management's NAMS Position: Q3 2026 in Review
SEB Asset Management reduced its NewAmsterdam Pharma (NAMS) stake by 37% in Q3 2026, selling an estimated $2.82M and leaving 170,752 shares worth $4.15M. The position accounts for 0.02% of the portfolio, ranked #480.
SEB Asset Management first reported a position in NAMS in Q1 2026 and has held it in 3 quarters since. The position peaked at $9.24M in Q2 2026. 160 funds tracked by Wall St. Rank hold NAMS as of Q3 2026.
- SEB Asset Management held 170,752 shares of NewAmsterdam Pharma worth $4.15M as of Q3 2026.
- SEB Asset Management sold 101,902 NewAmsterdam Pharma shares in Q3 2026, an estimated $2.82M.
- NewAmsterdam Pharma made up 0.02% of SEB Asset Management's portfolio in Q3 2026, its #480 holding.
- SEB Asset Management first reported a position in NewAmsterdam Pharma in Q1 2026 and has held it in 3 quarters since.
- SEB Asset Management's NewAmsterdam Pharma position peaked at $9.24M in Q2 2026.
- 160 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q3 2026.
Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.